Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Emergent Biosolutions

(NYSE: EBS)
Add to Portfolio
+0.61 (+11.98%)
as of May 31, 2024


Date Form Description HTML Word PDF Excel
May 02, 2024 10-Q Quarterly Report
May 01, 2024 8-K Current report filing
May 01, 2024 8-K Current report filing
Apr 30, 2024 8-K Current report filing
Apr 26, 2024 8-K Current report filing
Apr 11, 2024 ARS Annual Report to Security Holders  
Apr 11, 2024 DEFA14A Additional Proxy Soliciting Materials (definitive)  
Apr 11, 2024 DEF 14A Proxy Statement (definitive)  
Mar 08, 2024 10-K Annual Report
Mar 06, 2024 8-K Current report filing
Feb 21, 2024 8-K Current report filing
Feb 09, 2024 SC 13G Statement of Ownership  
Jan 11, 2024 8-K Current report filing
Jan 09, 2024 8-K Current report filing
Dec 13, 2023 S-8 POS Post-Effective Amendment to an S-8 filing  
Dec 11, 2023 10-Q Quarterly Report
Dec 11, 2023 10-K/A Amended Annual Report
Dec 11, 2023 S-8 Securities Registration: Employee Benefit Plan  
Nov 28, 2023 8-K Current report filing
Nov 24, 2023 8-K Current report filing
Nov 16, 2023 8-K Current report filing
Nov 09, 2023 NT 10-Q Notification that Quarterly Report will be submitted late  
Nov 08, 2023 8-K Current report filing
Oct 05, 2023 8-K Current report filing
Oct 02, 2023 8-K Current report filing